Aaron G.L. Fletcher

Insider Reports History

Location
Boston, MA
Signature
Aaron G.L. Fletcher By: /s/ John Fucci, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Aaron G.L. Fletcher:

Company Role Class Num Shares Value Price $ Report Date Ownership
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 2,506,667 $27,523,203 $10.98 27 Jun 2025 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 2,094,650 $22,999,257 $10.98 27 Jun 2025 Directly held by Bios Actuate Co-Invest II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 1,259,427 $13,828,508 $10.98 27 Jun 2025 Directly held by Bios Clinical Opportunity Fund, LP
Azitra Inc 10%+ Owner Common Stock 2,643,705 $13,218,525 $5.00 21 Jun 2023 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 980,433 $10,765,154 $10.98 27 Jun 2025 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 573,394 $6,295,866 $10.98 27 Jun 2025 Directly held by Bios Actuate Co-Invest III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 525,797 $5,773,251 $10.98 27 Jun 2025 Directly held by Bios Fund I, LP
Azitra Inc 10%+ Owner Common Stock 1,023,442 $5,117,210 $5.00 21 Jun 2023 Directly held by Bios Fund II QP, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 2,021,906 $5,014,326 $2.48 19 Sep 2025 By Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 404,814 $4,444,857 $10.98 27 Jun 2025 Directly held by Bios Fund III NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 383,791 $4,214,025 $10.98 27 Jun 2025 Directly held by Bios Fund III, LP
Azitra Inc 10%+ Owner Common Stock 799,467 $3,997,335 $5.00 21 Jun 2023 Directly held by Bios Fund I, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 1,424,014 $3,531,554 $2.48 19 Sep 2025 By Bios Memory SPV I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 307,538 $3,376,767 $10.98 27 Jun 2025 Directly held by Bios Fund I QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 300,749 $3,302,224 $10.98 27 Jun 2025 Directly held by Bios Actuate Co-Invest I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 300,143 $3,295,570 $10.98 27 Jun 2025 Directly held by Bios Fund II, LP
Azitra Inc 10%+ Owner Common Stock 467,613 $2,338,065 $5.00 21 Jun 2023 Directly held by Bios Fund I QP, LP
Azitra Inc 10%+ Owner Common Stock 436,173 $2,180,865 $5.00 21 Jun 2023 Directly held by Bios Azitra Co-Invest I, LP
Azitra Inc 10%+ Owner Common Stock 426,944 $2,134,720 $5.00 21 Jun 2023 Directly held by Bios Fund III NT, LP
Azitra Inc 10%+ Owner Common Stock 404,767 $2,023,835 $5.00 21 Jun 2023 Directly held by Bios Fund III, LP
Azitra Inc 10%+ Owner Common Stock 313,250 $1,566,250 $5.00 21 Jun 2023 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 131,248 $1,441,103 $10.98 27 Jun 2025 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 196,428 $1,374,996 $7.00 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 500,095 $1,240,235 $2.48 19 Sep 2025 By Bios Clinical Opportunity Fund, LP
Lantern Pharma Inc. 10%+ Owner Common Stock 373,178 $1,153,120 $3.09 13 Jun 2025 By Bios Fund II QP, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 418,926 $1,038,936 $2.48 19 Sep 2025 By Bios Fund I, LP
Lantern Pharma Inc. 10%+ Owner Common Stock 323,335 $999,105 $3.09 13 Jun 2025 By Bios Fund I, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 385,248 $955,415 $2.48 19 Sep 2025 By Bios Memory SPV II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 84,917 $932,388 $10.98 27 Jun 2025 Directly held by BP Directors, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 326,733 $810,297 $2.48 19 Sep 2025 By Bios Fund III NT, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 309,748 $768,175 $2.48 19 Sep 2025 By Bios Fund III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 69,375 $761,737 $10.98 27 Jun 2025 Directly held by Circle K Invesco, LP
Azitra Inc 10%+ Owner Common Stock 137,000 $685,000 $5.00 21 Jun 2023 Directly held by Bios Fund II NT, LP
Azitra Inc 10%+ Owner Common Stock 135,808 $679,040 $5.00 21 Jun 2023 Direct
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 60,973 $669,483 $10.98 27 Jun 2025 Directly held by Aaron G.L. Fletcher
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 255,765 $634,297 $2.48 19 Sep 2025 By Bios Fund II QP, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 245,029 $607,671 $2.48 19 Sep 2025 By Bios Fund I QP, LP
Lantern Pharma Inc. 10%+ Owner Common Stock 189,117 $584,371 $3.09 13 Jun 2025 By Bios Fund I QP, LP
IN8BIO, INC. 10%+ Owner Common Stock 3,727,597 $559,139 $0.1500 02 May 2025 By Bios Fund III QP, LP
Lantern Pharma Inc. 10%+ Owner Common Stock 114,272 $353,100 $3.09 13 Jun 2025 by Bios Fund II, LP
IN8BIO, INC. 10%+ Owner Common Stock 1,876,624 $281,493 $0.1500 02 May 2025 By Bios Fund II QP, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 78,298 $194,179 $2.48 19 Sep 2025 By Bios Fund II, LP
SWK Holdings Corp Director Common Stock 9,873 $177,220 $17.95 31 Dec 2021 Direct
Lantern Pharma Inc. 10%+ Owner Common Stock 49,957 $154,367 $3.09 13 Jun 2025 By Bios Fund II NT, LP
IN8BIO, INC. 10%+ Owner Common Stock 997,433 $149,614 $0.1500 02 May 2025 By BIOS Incysus Co-Invest I, LP
Lantern Pharma Inc. 10%+ Owner Common Stock 26,093 $100,718 $3.86 13 Jun 2025 By BP Directors, LP
IN8BIO, INC. 10%+ Owner Common Stock 601,980 $90,297 $0.1500 02 May 2025 By Bios Fund III, NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 8,056 $88,454 $10.98 27 Jun 2025 Directly held by KF Legacy Trust U/A/D December 7, 2016
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Common Stock 8,056 $88,454 $10.98 27 Jun 2025 Directly held by MF Legacy Trust U/A/D December 7, 2016
IN8BIO, INC. 10%+ Owner Common Stock 574,432 $86,164 $0.1500 02 May 2025 By Bios Fund II, LP
IN8BIO, INC. 10%+ Owner Common Stock 570,724 $85,608 $0.1500 02 May 2025 By Bios Fund III, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 34,238 $84,910 $2.48 19 Sep 2025 By Bios Fund II NT, LP
Azitra Inc 10%+ Owner Common Stock 13,106 $65,530 $5.00 21 Jun 2023 Directly held by KF Legacy Trust
Azitra Inc 10%+ Owner Common Stock 13,106 $65,530 $5.00 21 Jun 2023 Directly held by MF Legacy Trust
COGNITION THERAPEUTICS INC Director, 10%+ Owner Common Stock 56,229 $47,232 $0.8400 19 Sep 2025 Direct
IN8BIO, INC. 10%+ Owner Common Stock 251,211 $37,681 $0.1500 02 May 2025 By Bios Fund II NT, LP
IN8BIO, INC. 10%+ Owner Pre-Funded Warrants 2,431,763 02 May 2025 By Bios Clinical Opportunity Fund, LP
IN8BIO, INC. 10%+ Owner Series C Warrant 709,040 02 May 2025 By Bios Clinical Opportunity Fund, LP
IN8BIO, INC. 10%+ Owner Stock Option 85,000 02 May 2025 Indirect
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 71,428 27 Jun 2025 Directly held by Bios 2024 Co-Invest, LP
TFF Pharmaceuticals, Inc. Director Stock Options (Right to Buy) 33,475 29 Dec 2022 To BP Directors for the benefit of Reporting Person
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Stock Options 31,884 12 Aug 2024 Directly held by BP Directors, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Stock Options 15,000 22 May 2025 Direct
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Stock Options 15,000 12 Aug 2024 Directly held by Aaron G.L. Fletcher
Cue Biopharma, Inc. Director Stock Option (right to buy) 10,000 03 Jan 2023 Direct
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Convertible Note 0 14 Aug 2024 Directly held by Bios Clinical Opportunity Fund, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series A Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series A Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund I QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Actuate Co-Invest I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-1 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Actuate Co-Invest I, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-2 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-3 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-3 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-3 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund II QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Actuate Co-Invest II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund III NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series B-4 Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Actuate Co-Invest III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund III, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund III NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Series C Redeemable Convertible Preferred Stock 0 14 Aug 2024 Directly held by Bios Fund III QP, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 0 14 Aug 2024 Directly held by Bios Fund II, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 0 14 Aug 2024 Directly held by Bios Fund II NT, LP
ACTUATE THERAPEUTICS, INC. Director, 10%+ Owner Warrant (Right to Buy) 0 14 Aug 2024 Directly held by Bios Fund II QP, LP
Azitra Inc 10%+ Owner Convertible Notes 0 21 Jun 2023 Directly held by Bios Fund III, LP
Azitra Inc 10%+ Owner Convertible Notes 0 21 Jun 2023 Directly held by Bios Fund III NT, LP
Azitra Inc 10%+ Owner Convertible Notes 0 21 Jun 2023 Directly held by Bios Fund III QP, LP
Azitra Inc 10%+ Owner Series A-1 Convertible Preferred Stock 0 21 Jun 2023 Directly held by Bios Azitra Co-Invest I, LP
Azitra Inc 10%+ Owner Series A-1 Convertible Preferred Stock 0 21 Jun 2023 Directly held by Bios Fund II, LP
Azitra Inc 10%+ Owner Series A-1 Convertible Preferred Stock 0 21 Jun 2023 Directly held by Bios Fund II NT, LP
Azitra Inc 10%+ Owner Series A-1 Convertible Preferred Stock 0 21 Jun 2023 Directly held by Bios Fund II QP, LP
Azitra Inc 10%+ Owner Series A Convertible Preferred Stock 0 21 Jun 2023 Directly held by Bios Fund I, LP
Azitra Inc 10%+ Owner Series A Convertible Preferred Stock 0 21 Jun 2023 Directly held by Bios Fund I QP, LP
Azitra Inc 10%+ Owner Series B Convertible Preferred Stock 0 21 Jun 2023 Directly held by Bios Fund III, LP
Azitra Inc 10%+ Owner Series B Convertible Preferred Stock 0 21 Jun 2023 Directly held by Bios Fund III NT, LP
Azitra Inc 10%+ Owner Series B Convertible Preferred Stock 0 21 Jun 2023 Directly held by Bios Fund III QP, LP
Azitra Inc 10%+ Owner Series B Convertible Preferred Stock 0 21 Jun 2023 Directly held by Bios Fund II, LP
Azitra Inc 10%+ Owner Series B Convertible Preferred Stock 0 21 Jun 2023 Directly held by Bios Fund II NT, LP
Azitra Inc 10%+ Owner Series B Convertible Preferred Stock 0 21 Jun 2023 Directly held by Bios Fund II QP, LP
COGNITION THERAPEUTICS INC Director, 10%+ Owner Stock Option (right to buy) 0 19 Sep 2025 Direct
IN8BIO, INC. 10%+ Owner Series A Warrant 0 02 May 2025 By Bios Clinical Opportunity Fund, LP
IN8BIO, INC. 10%+ Owner Series B Warrant 0 02 May 2025 By Bios Clinical Opportunity Fund, LP

Insider Reports Filed by Aaron G.L. Fletcher

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CGTX COGNITION THERAPEUTICS INC 19 Sep 2025 2 +$6,492 4 Director, 10%+ Owner 23 Sep 2025, 21:54
ACTU ACTUATE THERAPEUTICS, INC. 27 Jun 2025 2 +$499,996 4 Director, 10%+ Owner 30 Jun 2025, 13:01
CGTX COGNITION THERAPEUTICS INC 18 Jun 2025 1 $0 4 Director, 10%+ Owner 20 Jun 2025, 17:38
LTRN Lantern Pharma Inc. 13 Jun 2025 5 -$123,600 4 10%+ Owner 13 Jun 2025, 19:57
LTRN Lantern Pharma Inc. 10 Jun 2025 15 -$208,271 4 10%+ Owner 13 Jun 2025, 06:06
LTRN Lantern Pharma Inc. 27 May 2025 15 -$168,419 4 10%+ Owner 29 May 2025, 21:55
ACTU ACTUATE THERAPEUTICS, INC. 22 May 2025 1 $0 4 Director, 10%+ Owner 23 May 2025, 16:05
INAB IN8BIO, INC. 02 May 2025 3 $0 4 10%+ Owner 07 May 2025, 21:48
INAB IN8BIO, INC. 04 Oct 2024 4 $0 4 10%+ Owner 11 Oct 2024, 18:12
ACTU ACTUATE THERAPEUTICS, INC. 12 Aug 2024 3 -$199,992 4/A Director, 10%+ Owner 20 Aug 2024, 20:46
ACTU ACTUATE THERAPEUTICS, INC. 12 Aug 2024 0 $0 4 Director, 10%+ Owner 14 Aug 2024, 20:51
ACTU ACTUATE THERAPEUTICS, INC. 12 Aug 2024 56 +$3,975,011 4 Director, 10%+ Owner 14 Aug 2024, 20:49
ACTU ACTUATE THERAPEUTICS, INC. 12 Aug 2024 0 $0 3 Director, 10%+ Owner 12 Aug 2024, 18:30
CGTX COGNITION THERAPEUTICS INC 07 Jun 2024 2 $0 4 Director, 10%+ Owner 11 Jun 2024, 21:32
LTRN Lantern Pharma Inc. 23 May 2024 6 -$189,100 4 10%+ Owner 28 May 2024, 16:30
LTRN Lantern Pharma Inc. 27 Feb 2024 9 -$676,294 4 10%+ Owner 29 Feb 2024, 21:54
LTRN Lantern Pharma Inc. 17 Jan 2024 9 +$1.93 4 10%+ Owner 19 Jan 2024, 16:31
INAB IN8BIO, INC. 13 Dec 2023 3 $0 4 10%+ Owner 14 Dec 2023, 06:00
LTRN Lantern Pharma Inc. 29 Nov 2023 2 -$499,997 4 10%+ Owner 01 Dec 2023, 06:01
CGTX COGNITION THERAPEUTICS INC 08 Nov 2023 1 +$525,100 4 Director, 10%+ Owner 13 Nov 2023, 09:47
AZTR Azitra Inc 21 Jun 2023 33 +$3,000,000 4 10%+ Owner 23 Jun 2023, 21:37
AZTR Azitra Inc 15 Jun 2023 0 $0 3 10%+ Owner 15 Jun 2023, 17:57
CGTX COGNITION THERAPEUTICS INC 09 Jun 2023 2 $0 4 Director, 10%+ Owner 13 Jun 2023, 20:01
CUE Cue Biopharma, Inc. 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 15:08
/report/000121390022084087-fletcher-aaron-g-l-2022-12-29 TFF Pharmaceuticals, Inc. 29 Dec 2022 1 $0 4 Director 30 Dec 2022, 15:52
INAB IN8BIO, INC. 12 Dec 2022 3 +$185,912 4 Director, 10%+ Owner 13 Dec 2022, 06:00
CGTX COGNITION THERAPEUTICS INC 28 Nov 2022 3 +$42,565 4 Director, 10%+ Owner 29 Nov 2022, 06:02
/report/000121390022074720-fletcher-aaron-g-l-2022-11-22 TFF Pharmaceuticals, Inc. 22 Nov 2022 2 +$49,990 4 Director 23 Nov 2022, 06:59
CGTX COGNITION THERAPEUTICS INC 16 Nov 2022 3 +$99,400 4 Director 17 Nov 2022, 06:00
CGTX COGNITION THERAPEUTICS INC 15 Nov 2022 3 +$1,800,000 4 Director 16 Nov 2022, 06:00
LTRN Lantern Pharma Inc. 08 Nov 2022 5 -$1,540,000 4 10%+ Owner 09 Nov 2022, 20:37
INAB IN8BIO, INC. 28 Sep 2022 3 +$50,535 4 Director, 10%+ Owner 29 Sep 2022, 06:14
LTRN Lantern Pharma Inc. 02 Sep 2022 6 +$0.14 4 10%+ Owner 07 Sep 2022, 16:55
INAB IN8BIO, INC. 26 Aug 2022 6 +$103,340 4 Director, 10%+ Owner 30 Aug 2022, 13:16
INAB IN8BIO, INC. 17 Aug 2022 3 +$96,500 4 Director, 10%+ Owner 18 Aug 2022, 19:16
INAB IN8BIO, INC. 16 Aug 2022 3 +$3,370,000 4 Director, 10%+ Owner 17 Aug 2022, 10:25
CGTX COGNITION THERAPEUTICS INC 10 Jun 2022 3 $0 4/A Director, 10%+ Owner 30 Jun 2022, 12:06
CGTX COGNITION THERAPEUTICS INC 10 Jun 2022 3 $0 4 Director, 10%+ Owner 14 Jun 2022, 19:57
CUE Cue Biopharma, Inc. 23 May 2022 2 +$711,700 4 Director 25 May 2022, 09:09
/report/000121390022027797-fletcher-aaron-g-l-2022-05-16 TFF Pharmaceuticals, Inc. 16 May 2022 2 +$538,068 4 Director 17 May 2022, 21:57
/report/000121390022017959-fletcher-aaron-g-l-2022-04-04 TFF Pharmaceuticals, Inc. 04 Apr 2022 2 +$3,504,380 4 Director 04 Apr 2022, 18:34
CUE Cue Biopharma, Inc. 31 Mar 2022 1 +$3,498,600 4 Director 04 Apr 2022, 17:28
CGTX COGNITION THERAPEUTICS INC 31 Jan 2022 2 $0 4 Director, 10%+ Owner 01 Feb 2022, 18:51
CUE Cue Biopharma, Inc. 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 20:14
SWKH SWK Holdings Corp 31 Dec 2021 1 $0 4 Director 12 Jan 2022, 13:20
SWKH SWK Holdings Corp 31 Dec 2021 1 $0 4 Director 03 Jan 2022, 18:38
CGTX COGNITION THERAPEUTICS INC 13 Oct 2021 1 $0 4/A Director, 10%+ Owner 01 Feb 2022, 18:03
CGTX COGNITION THERAPEUTICS INC 07 Oct 2021 0 $0 3/A Director, 10%+ Owner 01 Feb 2022, 17:22
SWKH SWK Holdings Corp 30 Sep 2021 2 $0 4 Director 01 Oct 2021, 17:49
INAB IN8BIO, INC. 13 Aug 2021 2 $0 4 10%+ Owner 17 Aug 2021, 20:18
INAB IN8BIO, INC. 03 Aug 2021 14 $0 4 10%+ Owner 03 Aug 2021, 16:53
INAB IN8BIO, INC. 29 Jul 2021 0 $0 3 10%+ Owner 29 Jul 2021, 21:37
SWKH SWK Holdings Corp 30 Jun 2021 1 $0 4 Director 30 Jun 2021, 17:54